ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

ACS, In Reorganization, To Emphasize Funds for Young Scientists

January 12, 1996

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011

NCAB Can’t Decide Fate of Women’s Health Trial, Forces It Back Into Lap of DCPC Scientific Advisors

October 2, 1987

Avastin Improves PFS In Advanced Breast Cancer

April 29, 2005

Pitt Cancer Center Director Herberman Issues “Precautionary Advice” On Cell Phone Use.

July 25, 2008

MD Anderson Survey Shows Faculty Dissatisfaction with Top Leaders

May 23, 2014